BioCentury | Jul 12, 2018
Translation in Brief
New Therapeutic Targets and Biomarkers: June 2018
...inhibiting CTU2 or ELP3 could help treat drug-resistant BRAF-mutant melanoma University of Liège Distillery Therapeutics Elongator acetyltransferase complex subunit 3 (ELP3)...